Estimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019

Varniab, Zahra Shokri; Tehrani, Yeganeh Sharifnejad; Langroudi, Ashkan Pourabhari; Azadnajafabad, Sina; Rezaei, Negar; Rashidi, Mohammad‐Mahdi; Esfahani, Zahra; Malekpour, Mohammad‐Reza; Ghasemi, Erfan; Ghamari, Azin; Dilmaghani‐Marand, Arezou; Fateh, Sahar Mohammadi; Shabestari, Alireza Namazi; Larijani, Bagher; Farzadfar, Farshad

doi:10.1002/cam4.4792

Cited by 3 publications

(4 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lung cancer had an increasing trend in men and women, and incidence rates of lung cancer were twice as high in men as in women. Overall, these findings are in accordance with findings reported in a study about lung cancer at the national and sub‐national levels 15 . This difference between men and women could explain by the prevalence of smoking is higher in men than in women 37 .…”

Section: Discussionsupporting

confidence: 92%

“…Overall, these findings are in accordance with findings reported in a study about lung cancer at the national and sub‐national levels. 15 This difference between men and women could explain by the prevalence of smoking is higher in men than in women. 37 As smoking is more prevalent among men than women, women are at a high risk of secondhand smoking.…”

Section: Discussionmentioning

confidence: 99%

“…Population aging has been attributed to the difference between the second and first hypothetical data. The differences between the incidence rates of new cases in 2016 and hypothetical data were explained by the changes in the incidence rates of specific age groups 15 . We calculated the max/min ratio in 1990 and 2019 for ASIR by gender to describe the disparities in 31 provinces.…”

Section: Methodsmentioning

confidence: 99%

“…The differences between the incidence rates of new cases in 2016 and hypothetical data were explained by the changes in the incidence rates of specific age groups. 15 We calculated the max/min ratio in 1990 and 2019 for ASIR by gender to describe the disparities in 31 provinces. In cases where there were no considerable differences among them, we reported the maximum and minimum ASIR among all 31 provinces.…”

Section: Methodsmentioning

confidence: 99%

See 3 more Smart Citations

The levels and trends of cancer incidence in the elderly population at national and sub‐national scales in Iran from 1990 to 2016

Shokri Varniab,

Saeedi Moghaddam,

Pourabhari Langroudi

et al. 2023

Cancer Reports

Self Cite

View full text Add to dashboard Cite

BackgroundCancer is most commonly associated with aging. It is necessary to gain a better understanding of cancer's trend and distribution among elderlies and provide comprehensive cancer care for this population.AimsThe aim of the current study was to show the trends in cancer incidence focusing on the population aged 60+ from 1990 to 2016 in Iran.Material and ResultsWe used the dataset of the Iran Cancer Registry to estimate cancer incidences by sex, age, province, and year. In order to account for incomplete data we used a two‐stage spatiotemporal model along with random intercept mixed effect models. We calculated annual age‐standardized incidence rates (ASIRs) for age groups 60+ and 5‐interval age groups. There was an increasing trend of 25.3% to 936.9% (95% uncertainty interval: 769.6–1141.8) in ASIR in the elderly in 2016. ASIR of all cancers were 889.7 (731.3–1083.6) in women and 988.1 (811.1–1205) in men in 2016, per 100 000 respectively, which had an increasing trend comparing 1990. Skin, breast, and stomach cancers in women and prostate, skin, and stomach cancers in men were the most common types in 2016. All the most incident cancer subtypes underwent an increasing trend in both sexes, except for the bladder, esophageal, and skin cancers which almost had a similar level in 1990 and 2016. Most provinces had an increasing trend in ASIR in all cancers combined from 1990 to 2016 except Zanjan with a decreasing trend.ConclusionRegarding the persistent increasing trend of most elderly cancers' incidence, this is crucial for policymakers to establish preventive plans, determine proper resource allocation, and develop specific treatments for elderly cancer patients.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

The levels and trends of cancer incidence in the elderly population at national and sub‐national scales in Iran from 1990 to 2016

Shokri Varniab,

Saeedi Moghaddam,

Pourabhari Langroudi

et al. 2023

Cancer Reports

Self Cite

View full text Add to dashboard Cite

show abstract

Estimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background: Lung cancer is one of the leading cancers, with a high burden worldwide. As a developing country, Iran is facing with population growth, widespread tobacco use, demographic and epidemiologic changes, and environmental exposures, which lead to cancers becoming a severe concern of public health in Iran. We aimed to examine the burden of lung cancer and its risk factors in Iran. Methods:We utilized the Global Burden of Disease 2019 data and analyzed the total burden of the lung cancer and seven related risk factors by sex, age at national and sub-national levels from 1990 to 2019. Results:The lung cancer age-standardized death rate increased from 11.8 (95% Uncertainty Interval: 9.7-14.4) to 12.9 (11.9-13.9) per 100,000 between 1990 and 2019. This increase was among women from 5 (4.2-7.1) to 8 (7.2-8.8) per 100,000; in contrast, there was a decline among men from 18.5 (14.8-22.6) to 17.8 (16.2-19.4) per 100,000. The burden of lung cancer is concentrated in the advanced age groups. Smoking with 53.5% of total attributable deaths (51.0%-55.9%) was the leading risk factor. At the provincial level, there was a wide range between the lowest and highest, from 8.3 (7.0-10.0) to 19.1 (16.4-22.0) per 100,000 population in the incidence rate and from 8.

show abstract

Mortality and disability-adjusted life years for smoking-attributed cancers from 1990 to 2019 in the north Africa and middle east countries: a systematic analysis for the global burden of disease study 2019

et al. 2023

View full text Add to dashboard Cite

Aim and background Smoking is a modifiable risk factor for cancers. The aim of the study is to estimate the trend of mortality and DALYs of smoking-attributed cancers in the North Africa and Middle East (NAME) countries. Methods In this study, estimates from the Global Burden of Disease 2019 (GBD-2019) study were used to report the mortality and DALYs for 16 smoking-attributed cancers. The mortality and DALYs rates from smoking-attributed cancers were evaluated by age, sex, and the 21 countries of the NAME countries from 1990 to 2019. Results Age standardized mortality rates (ASMR) for the 29 smoking-attributed cancers in the NAME countries in 1990 and 2019 were estimated to be 24.7 (95% Uncertainty Interval: 21.5, 27.8) and 22.4 (95%UI: 19.8, 25.4) respectively, which shows a 9.2% decrease in the three decades. DALYs/100,000 for smoking-attributed cancers was, also, estimated to be 600.3 (95%UI: 521.6, 682.6) and 515.6 (95%UI: 454.9, 585.4) respectively, which indicates a 14.1% decreased in these three decades. In the last three decades, the percentage changes in DALYs/100,000 for smoking-attributed cancers in males and females were − 0.16 and − 0.03, respectively. Plus, The percentage changes in ASMR in males and females were − 12% and 8%, respectively. Furthermore, The highest ASMR and DALYs were observed in Lebanon, Turkey, and Palestine in 2019. Conclusion The mortality rates of cancers from smoking have increased substantially among females, in most countries of the NAME region, in recent years. The burden caused by smoking can be reduced through modifying lifestyle and applying strict laws on smoking by governments and policymakers.

show abstract

Estimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019

Cited by 3 publications

References 53 publications

The levels and trends of cancer incidence in the elderly population at national and sub‐national scales in Iran from 1990 to 2016

The levels and trends of cancer incidence in the elderly population at national and sub‐national scales in Iran from 1990 to 2016

Estimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019

Mortality and disability-adjusted life years for smoking-attributed cancers from 1990 to 2019 in the north Africa and middle east countries: a systematic analysis for the global burden of disease study 2019

Contact Info

Product

Resources

About